STAPOKIBART
UNII L2REN9TU2D

Substance Identification & Data

This profile provides standardized clinical and technical data for Stapokibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L2REN9TU2D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2734715-10-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L2REN9TU2D

CAS Registry Number

2734715-10-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

STAPOKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188799

National Cancer Institute reference terminology for clinical and research data.

INN ID

12443

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Stapokibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

STAPOKIBART

Common Names & Synonyms

CM-310 (ANTI-IL-4R IGG4 MONOCLONAL ANTIBODY)

IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN INTERLEUKIN 4 RECEPTOR SUBUNIT .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL CM310 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CM310 .KAPPA.-CHAIN, DIMER

STAPOKIBART [INN]

STAPOKIBART [WHO-DD]